Impact of coronary artery disease on outcome after transcatheter edge-to-edge mitral valve repair with the MitraClip system

Giordano, Arturo; Pepe, Martino; Biondi‐Zoccai, Giuseppe; Corcione, Nicola; Finizio, Filippo; Ferraro, Paolo; Denti, Paolo; Rubbio, Antonio Popolo; Petronio, Sonia; Bartorelli, Antonio L.; Nestola, Palma Luisa; Mongiardo, Annalisa; Felice, Francesco De; Adamo, Marianna; Montorfano, Matteo; Baldi, Carlo; Tarantini, Giuseppe; Giannini, Francesco; Ronco, Federico; Monteforte, Ida; VILLA, Emmanuel; Ormezzano, Maurizio Ferrario; Fiocca, Luigi; Castriota, Fausto; Bedogni, Francesco; Tamburino, Corrado

doi:10.23736/s0031-0808.23.04827-9

Panminerva Med

2023

DOI: 10.23736/s0031-0808.23.04827-9

|View full text |Cite

Impact of coronary artery disease on outcome after transcatheter edge-to-edge mitral valve repair with the MitraClip system

Arturo Giordano

Martino Pepe

Giuseppe Biondi‐Zoccai

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mitral regurgitation is a common cause of morbidity and mortality worldwide, and poses several challenges, especially when significant comorbidities coexist. 1 , 2 , 3 , 4 While surgical mitral valve repair (SMVR) has been considered the gold‐standard treatment of mitral regurgitation for several decades, its invasiveness is still a limitation, especially in patients at increased surgical risk. 5 , 6 Transcatheter edge‐to‐edge repair (TEER) was introduced several years ago as a minimally invasive alternative to SMVR in carefully selected cases, and, despite some inconsistencies between pivotal trials, TEER has become a mainstay in the management of mitral regurgitation.…”

mentioning

confidence: 99%

Transcatheter Mitral Valve Repair With the MitraClip Device for Prior Mitral Valve Repair Failure: Insights From the GIOTTO‐FAILS Study

Giordano,

Ferraro,

Finizio

et al. 2024

JAHA

Self Cite

View full text Add to dashboard Cite

Background Minimally invasive mitral valve repair has a favorable risk–benefit profile in patients with significant de novo mitral regurgitation. Its role in patients with prior mitral valve repair is uncertain. We aimed to appraise the outcome of patients undergoing transcatheter edge‐to‐edge repair (TEER) with prior transcatheter or surgical mitral valve repair (SMVR). Methods and Results We queried the Italian multicenter registry on TEER with MitraClip, distinguishing naïve patients from those with prior TEER or (SMVR). Inhospital and long‐term clinical/echocardiographic outcomes were appraised. The primary outcome was the occurrence of death or rehospitalization for heart failure. A total of 2238 patients were included, with 2169 (96.9%) who were naïve to any mitral intervention, 29 (1.3%) with prior TEER, and 40 (1.8%) with prior SMVR. Several significant differences were found in baseline clinical and imaging features. Respectively, device success was obtained in 2120 (97.7%), 28 (96.6%), and 38 (95.0%, P =0.261) patients; procedural success in 2080 (95.9%), 25 (86.2%), and 38 (95.0%; P =0.047); and inhospital death in 61 (2.8%), 1 (3.5%), and no ( P =0.558) patients. Clinical follow‐up after a mean of 14 months showed similar rates of death, cardiac death, rehospitalization, rehospitalization for heart failure, and their composite (all P >0.05). Propensity score–adjusted analysis confirmed unadjusted analysis, with lower procedural success for the prior TEER group (odds ratio, 0.28 [95% CI, 0.09–0.81]; P =0.019) but similar odds ratios and hazard ratios for all other outcomes in the naïve, TEER, and SMVR groups (all P >0.05). Conclusions In carefully selected patients, TEER can be performed using the MitraClip device even after prior TEER or SMVR.

show abstract

mentioning

confidence: 99%

Transcatheter Mitral Valve Repair With the MitraClip Device for Prior Mitral Valve Repair Failure: Insights From the GIOTTO‐FAILS Study

Giordano,

Ferraro,

Finizio

et al. 2024

JAHA

Self Cite

View full text Add to dashboard Cite

show abstract

Incidence and Predictors of Cerebrovascular Accidents in Patients Who Underwent Transcatheter Mitral Valve Repair With MitraClip

Giordano,

Ferraro,

Finizio

et al. 2024

The American Journal of Cardiology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Impact of coronary artery disease on outcome after transcatheter edge-to-edge mitral valve repair with the MitraClip system

Cited by 2 publications

References 28 publications

Transcatheter Mitral Valve Repair With the MitraClip Device for Prior Mitral Valve Repair Failure: Insights From the GIOTTO‐FAILS Study

Transcatheter Mitral Valve Repair With the MitraClip Device for Prior Mitral Valve Repair Failure: Insights From the GIOTTO‐FAILS Study

Incidence and Predictors of Cerebrovascular Accidents in Patients Who Underwent Transcatheter Mitral Valve Repair With MitraClip

Contact Info

Product

Resources

About